Administrative Core
行政核心
基本信息
- 批准号:10684150
- 负责人:
- 金额:$ 16.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-15 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AchievementAdvocateApplications GrantsChargeClinicalCommunicationCommunitiesDuchenne muscular dystrophyDystrophinEducationEnsureEnvironmentFamilyFosteringFoundationsGoalsInternationalJournalsKnowledgeLeadershipMaintenanceMedicineMethodsMissionModern MedicineMuscle CellsMuscular DystrophiesPatient CarePatientsPublic DomainsPublic HealthPublishingReagentResearchResearch PersonnelResourcesScienceSkeletal MuscleTraining and EducationUnited States National Institutes of HealthUpdateWorkbiobankclinical careempowermentgenome editinginnovationmeetingsmembernext generationnovel therapeuticsoutreachparent projectregenerativesymposiumweb site
项目摘要
Project Summary/Abstract for the Administrative Core
The Administrative Core of the UT Southwestern Senator Paul D. Wellstone Muscular Dystrophy Specialized
Research Center (MDSRC) will be responsible for the management and administration of the overall Center.
The primary goal of the Administrative Core is to ensure our Center remains successful in optimizing genome
editing or myoediting as a feasible and practical approach to treating Duchenne muscular dystrophy (DMD).
Achievement of the Center’s goal will be a transformative moment in modern medicine and will be a significant
contribution to the field of muscular dystrophy research as well as to patient care. In order for the UT
Southwestern Wellstone MDSRC to remain successful in its scientific endeavors, the Administrative Core will
continue to provide leadership amongst the various investigators within the Center in order to ensure efficient
use of resources and the successful completion of the goals outlined in this NIH P50 Grant Application. The
Administrative Core will provide an environment to facilitate the sharing and exchange of ideas and discoveries
within the Center as well as with the scientific community at-large. The Center will also actively seek to
disseminate these discoveries to patients and their families. The nurturing environment that exists at UT
Southwestern will foster the training and education of the next generation of clinical and scientific investigators
in the field of muscular dystrophy research. Finally, the UT Southwestern Administrative Core will continue its
effective communication with the NIH and Wellstone Network Consortium in order to collectively advance the
field of muscular dystrophy research forward. The goals set out by the Administrative Core will be
accomplished by pursuing the following three specific aims: Specific Aim 1: To facilitate and enhance clinical
and scientific interactions within the UT Southwestern Wellstone Muscular Dystrophy Specialized Research
Center. Specific Aim 2: To promote the dissemination of knowledge, resources, and discoveries related to
genome editing and Duchenne muscular dystrophy. Specific Aim 3: To serve as an advocate for and promote
outreach to muscular dystrophy patients and their families regarding novel therapeutics and advances in
clinical care. Under the continued effective leadership of the Administrative Core, the UT Southwestern
Senator Paul D. Wellstone MDSRC will strive to achieve its overarching goal of optimizing genome editing to
be an effective method of permanently restoring dystrophin expression within myocytes and thus provide a
long awaited therapy for DMD. Thus, the proposed NIH P50 Grant Application is relevant to and in keeping
with the mission of the NIH.
行政核心项目摘要/摘要
德克萨斯大学西南参议员 Paul D. Wellstone 肌肉萎缩症专业的行政核心
研究中心(MDSRC)将负责整个中心的管理和行政工作。
行政核心的主要目标是确保我们中心在优化基因组方面保持成功
编辑或肌编辑作为治疗杜氏肌营养不良症 (DMD) 的可行且实用的方法。
该中心目标的实现将成为现代医学的变革时刻,也将具有重大意义。
对肌营养不良症研究领域以及患者护理领域的贡献。为了UT
西南 Wellstone MDSRC 为了在其科学事业中保持成功,行政核心将
继续在中心内的各个调查员中提供领导,以确保高效
使用资源并成功完成本 NIH P50 拨款申请中概述的目标。这
行政核心将提供一个促进思想和发现的共享和交流的环境
中心内部以及整个科学界。中心还将积极争取
将这些发现传播给患者及其家人。 UT 的培养环境
西南航空将促进下一代临床和科学研究人员的培训和教育
在肌营养不良症研究领域。最后,德州大学西南行政核心将继续其
与 NIH 和 Wellstone 网络联盟进行有效沟通,共同推进
肌营养不良症研究领域的前沿。行政核心制定的目标将是
通过追求以下三个具体目标来实现: 具体目标 1:促进和加强临床
德克萨斯大学西南威尔斯通肌营养不良症专业研究中的科学互动
中心。具体目标 2:促进相关知识、资源和发现的传播
基因组编辑和杜氏肌营养不良症。具体目标 3:作为倡导者和促进
向肌营养不良症患者及其家人宣传新的治疗方法和进展
临床护理。在行政核心的持续有效领导下,UT西南大学
参议员 Paul D. Wellstone MDSRC 将努力实现其优化基因组编辑的总体目标
是永久恢复肌细胞内肌营养不良蛋白表达的有效方法,从而提供
期待已久的 DMD 治疗方法。因此,拟议的 NIH P50 拨款申请与相关并保持一致
NIH 的使命。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ERIC N Olson其他文献
ERIC N Olson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ERIC N Olson', 18)}}的其他基金
T-Cell-Mediated Inflammatory Response in Neonatal Heart Regeneration
新生儿心脏再生中 T 细胞介导的炎症反应
- 批准号:
10625954 - 财政年份:2023
- 资助金额:
$ 16.28万 - 项目类别:
Deciphering a Regulatory Circuit for Myocardial Metabolism and Energy Homeostasis
破译心肌代谢和能量稳态的调节回路
- 批准号:
8222523 - 财政年份:2011
- 资助金额:
$ 16.28万 - 项目类别:
Deciphering a Regulatory Circuit for Myocardial Metabolism and Energy Homeostasis
破译心肌代谢和能量稳态的调节回路
- 批准号:
8764734 - 财政年份:2011
- 资助金额:
$ 16.28万 - 项目类别:
Deciphering a Regulatory Circuit for Myocardial Metabolism and Energy Homeostasis
破译心肌代谢和能量稳态的调节回路
- 批准号:
8589000 - 财政年份:2011
- 资助金额:
$ 16.28万 - 项目类别:
Deciphering a Regulatory Circuit for Myocardial Metabolism and Energy Homeostasis
破译心肌代谢和能量稳态的调节回路
- 批准号:
8713680 - 财政年份:2011
- 资助金额:
$ 16.28万 - 项目类别:
相似海外基金
Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
- 批准号:
10760051 - 财政年份:2023
- 资助金额:
$ 16.28万 - 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
- 批准号:
2303692 - 财政年份:2023
- 资助金额:
$ 16.28万 - 项目类别:
Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
- 批准号:
468168 - 财政年份:2022
- 资助金额:
$ 16.28万 - 项目类别:
Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10427960 - 财政年份:2022
- 资助金额:
$ 16.28万 - 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
- 批准号:
10577074 - 财政年份:2022
- 资助金额:
$ 16.28万 - 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
- 批准号:
486588 - 财政年份:2022
- 资助金额:
$ 16.28万 - 项目类别:
Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
- 批准号:
2760091 - 财政年份:2022
- 资助金额:
$ 16.28万 - 项目类别:
Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10621188 - 财政年份:2022
- 资助金额:
$ 16.28万 - 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
- 批准号:
10891016 - 财政年份:2021
- 资助金额:
$ 16.28万 - 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
- 批准号:
10230365 - 财政年份:2020
- 资助金额:
$ 16.28万 - 项目类别:














{{item.name}}会员




